TSHA•benzinga•
Taysha Gene Therapies Huge Overhang Removed, Buried In 8-K On Friday; Has Elected Not To Move Forward With A Proposed Offering. Street Average Price Target Is $25 With 1000% Upside; No Offering Could Mean Partnership/Takeout - SEC
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga